Aggressive surgical interventions aiming at gross total resection have long been the standard treatment for most benign brain tumors, despite associated complications including disabling morbidity. Today, more than half of all cranial benign growths are alleviated surgically using less aggressive approaches, requiring an adjuvant treatment, such as stereotactic radiosurgery, to maximize tumor control. There is, however, no general consensus in determining when a resection is sufficient and when follow-up radiosurgery treatment is safe. Aiming to achieve the maximum safe surgical resection without any guidance may cause morbidity and irreversible neurological damage. Adaptive Hybrid Surgery Analysis automatically calculates and visualizes SRS/RT treatment plans, offering the possibility to combine the benefits of surgery with the benefits of radiosurgery.
On-the-fly feasibility analysis of adjuvant radiosurgery
Complete treatment workflow from planning to intraoperative decision-making
Support of interdisciplinary collaboration
Upfront integration of radiosurgery to avoid late referrals and potentially restricted treatment options